Literature DB >> 2157195

Insertional gene synthesis, a novel method of assembling consecutive DNA sequences within specific sites in plasmids. Construction of the HIV-1 tat gene.

R B Ciccarelli1, L A Loomis, P E McCoon, D L Holzschu.   

Abstract

The construction of the HIV-1 tat gene using a novel method termed insertional gene synthesis (IGS) is described. IGS is used to assemble a gene or any DNA sequence in a stepwise manner within a plasmid containing a single stranded DNA phage origin of replication. The IGS method is based upon consecutive targeted insertions of long DNA oligonucleotides (greater than 100 bases) within the plasmid by oligonucleotide-directed mutagenesis. IGS therefore involves synthesis of only a few oligonucleotides corresponding to one strand of a gene. Furthermore, the gene is synthesized directly adjacent to bacterial gene regulatory sequences for direct expression. Using this approach, the 261 bp tat gene was assembled in three successive cycles adjacent to the lac promoter in the pEMBL-derivative, pKH125. The 15 kD tat protein was produced from this synthetic gene in E. coli upon IPTG induction. However, it was necessary to tightly control the expression of tat by including the lac I gene directly within the tat expression vector.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2157195      PMCID: PMC330440          DOI: 10.1093/nar/18.5.1243

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  24 in total

1.  A rapid and versatile site-directed method of mutagenesis for double-stranded plasmid DNA.

Authors:  A V Bellini; F de Ferra; G Grandi
Journal:  Gene       Date:  1988-09-30       Impact factor: 3.688

2.  Use of oligonucleotides to generate large deletions.

Authors:  M K Eghtedarzadeh; S Henikoff
Journal:  Nucleic Acids Res       Date:  1986-06-25       Impact factor: 16.971

3.  A large fragment approach to DNA synthesis: total synthesis of a gene for the protease inhibitor eglin c from the leech Hirudo medicinalis and its expression in E. coli.

Authors:  H Rink; M Liersch; P Sieber; F Meyer
Journal:  Nucleic Acids Res       Date:  1984-08-24       Impact factor: 16.971

4.  Construction of improved M13 vectors using oligodeoxynucleotide-directed mutagenesis.

Authors:  J Norrander; T Kempe; J Messing
Journal:  Gene       Date:  1983-12       Impact factor: 3.688

5.  New M13 vectors for cloning.

Authors:  J Messing
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

6.  pEMBL: a new family of single stranded plasmids.

Authors:  L Dente; G Cesareni; R Cortese
Journal:  Nucleic Acids Res       Date:  1983-03-25       Impact factor: 16.971

7.  Improved oligonucleotide site-directed mutagenesis using M13 vectors.

Authors:  P Carter; H Bedouelle; G Winter
Journal:  Nucleic Acids Res       Date:  1985-06-25       Impact factor: 16.971

8.  Oligonucleotide-directed mutagenesis: a simple method using two oligonucleotide primers and a single-stranded DNA template.

Authors:  M J Zoller; M Smith
Journal:  DNA       Date:  1984-12

Review 9.  Total synthesis of a gene.

Authors:  H G Khorana
Journal:  Science       Date:  1979-02-16       Impact factor: 47.728

10.  Saccharomyces cerevisiae actin--Escherichia coli lacZ gene fusions: synthetic-oligonucleotide-mediated deletion of the 309 base pair intervening sequence in the actin gene.

Authors:  G P Larson; K Itakura; H Ito; J J Rossi
Journal:  Gene       Date:  1983-04       Impact factor: 3.688

View more
  3 in total

1.  Construction of synthetic genes using PCR after automated DNA synthesis of their entire top and bottom strands.

Authors:  R B Ciccarelli; P Gunyuzlu; J Huang; C Scott; F T Oakes
Journal:  Nucleic Acids Res       Date:  1991-11-11       Impact factor: 16.971

2.  Synthetic gene for the hepatitis C virus nucleocapsid protein.

Authors:  Y E Khudyakov; H A Fields; M O Favorov; N S Khudyakova; M T Bonafonte; B Holloway
Journal:  Nucleic Acids Res       Date:  1993-06-11       Impact factor: 16.971

3.  Random mutagenesis of the human immunodeficiency virus type-1 trans-activator of transcription (HIV-1 Tat).

Authors:  D P Siderovski; T Matsuyama; E Frigerio; S Chui; X Min; H Erfle; M Sumner-Smith; R W Barnett; T W Mak
Journal:  Nucleic Acids Res       Date:  1992-10-25       Impact factor: 16.971

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.